Separation Systems for Commercial Biotechnology Market Size, Share & Trends Analysis Report By Methods (Microarray, Lab-on-a-chip, Chromatography, Flow Cytometry, Biochip), By Application, And Segment Forecasts, 2018 - 2025

Report Overview

The global separation systems for commercial biotechnology market size was estimated at USD 12.92 billion in 2016. Driven by rising demand for novel drug molecules and cell-based therapies, commercial separation systems in the biotechnology industry are anticipated to witness significant growth in the forecast period.

Technological advancements in the field have been increasing. High throughput and accurate cell or molecule sorting techniques aid in a wide range of applications in various industries. Technologically advanced upstream bioprocessing technology enables the elimination of biohazardous by-products, reduces equipment size, and simplifies procedures.

Governments of various countries are providing financial assistance to small & medium enterprises to introduce novel technologies, in addition to developing & executing high-tech strategies for enhancement of commercial capabilities in this field. This is expected to drive industrial growth in the coming years.

Major advancements have been introduced in conventional methods, such as high-performance liquid chromatography, gas chromatography, supercritical fluid chromatography, centrifugation, and electrophoresis, for separation of large and sensitive molecules. These methods are majorly used in pharmaceutical, waste management, and food processing industries. In addition, modern methods, such as magnetic separators, are being used in commercial production of plastics, chemicals, and other industries.

Increasing demand for personalized medicines & cell-based therapies coupled with the recent global shortage of vaccines are placing new demands on this process, thus increasing the adoption of new technology-based systems for large -scale downstream bioprocessing. Pharmaceutical companies have a strong biopharmaceutical pipeline is rendering the growth of these instruments for purification of biomolecules from debris during its large production.

Industrial players are also entering into strategic partnerships with various research & academic institutions. Recently, researchers from Japan have developed a high-speed & efficient microfluidic chip device by using dual on-chip pumps. These high-speed systems can sort large cells with high viability and purity.

Methods Insights

Conventional methods hold the largest revenue share in separation systems for the commercial biotechnology market. Huge investments by industrial entities for advancements in techniques, such as flow cytometry and membrane filtration systems, for large-scale production are among the few factors boosting growth.

However, modern methods in the field of commercial biotechnology are anticipated to witness the fastest growth. Ongoing investigations are anticipated to propel the growth of the segment and fulfill global industrial demand for the bioseparation equipment market in the near future. 

Application Insights

The pharmaceutical industry accounts for the largest share in the purification and separation devices market. A combination of factors, such as existing universal shortage of vaccines, rising demand for biotherapies, and ongoing investigations in the field of novel drug development, are accelerating the growth of the segment.

Research organizations, in association with industrial partners, are intensively developing projects and producing lab-on-a-chip technology for industrial purposes, especially in the pharmaceutical segment. Most of the investigations are focused on advanced microfluidic devices that can separate biomolecules for various purposes, and this is projected to drive the market in the coming years.

Regional Insights

North America dominated the market, particularly the U.S., and holds the largest revenue share in the field of large-scale separation instruments. Factors likely to be responsible for the dominance of this segment are the local presence of established market players, continuous R&D, and technological advancements in the region, along with a well-established industrial & healthcare framework.

However, Asia Pacific is expected to emerge as the fastest-growing segment due to emerging economies in the region, increased R&D expenditure in the area of bioprocessing instruments, and government support in China & India. Furthermore, rising demand for therapeutics, a worldwide shortage of vaccines, and ongoing research in the field is anticipated to fuel revenue generation in this region.

Recently, researchers from Japan have developed the microfluidic chip device by using dual on-chip pumps. Such high-speed systems can sort large cells with high viability & high purity and are expected to stimulate advances in existing separation techniques available in the market. The new separators have high rotation speed and are applicable for separating small molecules from gases & liquids in various industries such as petrochemical, bioengineering, and chemical other than the pharmaceutical sector.

In addition to this, factors such as growing industrialization in both developed and developing nations, governmental support, suitable strategic framework, continuous R&D in the field are expected to drive the market in the near future.

Separation Systems for Commercial Biotechnology Market Share Insights

Major players in the market include Thermo Fisher Scientific; GE Healthcare; Agilent Technologies; Shimadzu Corporation; bioMérieux SA; Bio-Rad Laboratories, Inc.; Hitachi Koki Co., Ltd.; Merck & Co., Inc.; QIAGEN; WATERS; Sartorius; PerkinElmer, Inc.; Danaher; Miltenyi Biotec; and BD.

Currently, major players are forming strategic partnerships with other entities and collaborating to enhance their product portfolios in the field of separation systems to develop technologically advanced downstream processing systems.

Separation Systems for Commercial Biotechnology Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at the regional & country level and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this report, Grand View Research has segmented the separation systems for commercial biotechnology market on the basis of methods, application, and regions:

• Method Outlook (Revenue, USD Million; 2014 - 2025)

  • Modern methods

    • Microarray

    • Lab-on-a-chip

    • Biochip

    • Magnetic separation

  • Conventional methods

    • Chromatography

    • Flow cytometry

    • Membrane filtration

    • Electrophoresis

    • Centrifugation

• Application Outlook (Revenue, USD Million; 2014 - 2025)

  • Pharmaceutical

    • Vaccines

    • Proteins

    • Hormones/Insulin

    • Enzymes

    • Human Blood Plasma Fractionation

    • Mammalian Cell Cultures

  • Food & Cosmetics

  • Agriculture

  • Others

• Regional Outlook (Revenue, USD Million; 2014 - 2025)

  • North America

    • The U.S.

    • Canada

  • Europe

    • Germany

    • The U.K.

  • Asia Pacific

    • China

    • India

  • Latin America

    • Brazil

  • The Middle East and Africa (MEA)

    • South Africa